Table 1.
Baseline clinical characteristics of depressed patients participating in this study.
| Total (n = 78) | Mirtazapine (n = 40) | SSRIs (n = 38) | p | ||||
|---|---|---|---|---|---|---|---|
| % | % | % | |||||
| Sex (female) | 48.7% | 50.0% | 47.3% | n.s. | |||
| First episode | 68.4% | 71.1% | 65.8% | n.s. | |||
| Family psychiatric history | 29.2% | 25.7% | 32.4% | n.s. | |||
| Physical comorbidity | 38.7% | 35.1% | 42.1% | n.s. | |||
| Smoking | 2.7% | 5.4% | 0.0% | n.s. | |||
| Drinking | 22.7% | 23.7% | 21.6% | n.s. | |||
| Occupational status: Employed | 79.5% | 80.0% | 78.9% | n.s. | |||
| Mean | SD | Mean | SD | Mean | SD | ||
| Age | 47.7 | 16.8 | 48.4 | 16.4 | 47 | 17.4 | n.s. |
| Duration of current MDD episode (months) | 8.6 | 18.1 | 6 | 10 | 11.4 | 23.7 | 0.015 |
| HAM-D 17 items total score | 21 | 4.7 | 21.5 | 5.1 | 20.5 | 4.4 | n.s. |
SSRIs: selective serotonin reuptake inhibitors, MDD: major depressive disorder, HAM-D: Hamilton depression rating scale.